Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: J Allergy Clin Immunol. 2016 Jun 11;139(2):462–471.e14. doi: 10.1016/j.jaci.2016.04.037

Fig 1.

Fig 1

Dose-dependent effects of IL-13 and IL-17A in vivo. AHR in A/J mice treated with IL-13 or IL-17A i.t. (A,B), total cell counts from BAL fluid of cytokine treated animals (C,D), frequency of macrophages, lymphocytes, neutrophils, and eosinophils in the BAL fluid (E,F), CLCA3 and αTubulin expression and densitometry in total lung homogenates (G), total lung expression of IL-13 (H) and IL-17A (I) induced transcripts following cytokine treatment. #, ##, and ### indicate P<0.05, <0.01, and < 0.001 vs PBS. +, ++, and +++ in indicate P<0.05, <0.01, and < 0.001 vs IL-13. Mean + SEM of n=4-9 mice per group (pooled over 3 independent experiments) are shown.